// COMPANY
Consano Bio
SECTOR BIOTECHMENTIONS 1LAST SEEN OCTOBER 6, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·PitchBook News·OCTOBER 6, 2026
“Consano Bio, a biotech developing a biologic medication for chronic sciatica, raised a $15 million round.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.